Clinical Trial Update: Lorcaserin in Combination With XR-Naltrexone for Relapse Prevention in Opioid Use Disorder [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial evaluating lorcaserin in combination with XR-naltrexone for relapse prevention in opioid use disorder has completed with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Lorcaserin (lorcaserin)
• XR-Naltrexone (naltrexone)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Opioid-use Disorder | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2020-10-05